[Federal Register: August 9, 2007 (Volume 72, Number 153)]
[Notices]               
[Page 44858-44859]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09au07-82]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in schedule I or II and prior to issuing a 
registration under 21 U.S.C. 952(a)(2) authorizing the importation of 
such a substance, provide manufacturers holding registrations for the 
bulk manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with 21 CFR 1301.34(a), this is notice 
that on June

[[Page 44859]]

15, 2007, Alcan Packaging-Bethlehem, 2400 Baglyos Circle, Bethlehem, 
Pennsylvania 18020, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as an importer of Nabilone (7379) 
a basic class of controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for 
packaging and distribution.
    Any bulk manufacturer who is presently, or are applying to be, 
registered with DEA to manufacture such basic class of controlled 
substance may file comments or objections to the issuance of the 
proposed registration and may, at the same time, file a written request 
for a hearing on such application pursuant to 21 CFR 1301.43 and in 
such form as prescribed by 21 CFR 1316.47.
    Any such comments or objections being sent via regular mail should 
be addressed, in quintuplicate, to the Drug Enforcement Administration, 
Office of Diversion Control, Federal Register Representative (ODL), 
Washington, DC 20537, or any being sent via express mail should be sent 
to Drug Enforcement Administration, Office of Diversion Control, 
Federal Register Representative (ODL), 2401 Jefferson Davis Highway, 
Alexandria, Virginia 22301; and must be filed no later than September 
10, 2007.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR 1301.34(b), (c), 
(d), (e) and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975 (40 FR 43745-46), all applicants 
for registration to import a basic class of any controlled substances 
in schedule I or II are and will continue to be required to demonstrate 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, that the requirements for such 
registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 
1301.34(b), (c), (d), (e), and (f) are satisfied.

    Dated: July 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-15498 Filed 8-8-07; 8:45 am]

BILLING CODE 4410-09-P